# Innocoll clinical trials: 21 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with Innocoll as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Innocoll: 21 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/innocoll

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 8, 2021 | NCT04785638 | An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries | Innocoll | Phase 3 | Completed | Pain, Postoperative, Hernia, Ventral, Abdominoplasty, Hysterectomy, Colectomy, Reduction Mammoplasty | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04785638) |
| March 8, 2021 | NCT04785625 | Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty | Innocoll | Phase 3 | Completed | Pain, Postoperative, Abdominoplasty | 366 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04785625) |
| August 25, 2017 | NCT03262688 | Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair | Innocoll | Phase 3 | Unknown | Inguinal Hernia, Postoperative Pain | 159 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03262688) |
| July 31, 2017 | NCT03234374 | Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty | Innocoll | Phase 1 | Completed | Hernioplasty | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03234374) |
| August 17, 2015 | NCT02525133 | Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty | Innocoll | Phase 3 | Completed | Pain, Postoperative | 319 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02525133) |
| August 14, 2015 | NCT02523599 | Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty | Innocoll | Phase 3 | Completed | Pain, Postoperative | 305 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02523599) |
| May 18, 2015 | NCT02447172 | Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers | Innocoll | Phase 3 | Completed | Foot Ulcer, Diabetic, Infection | 524 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02447172) |
| April 28, 2015 | NCT02427802 | Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers | Innocoll | Phase 3 | Completed | Foot Ulcer, Diabetic, Infection | 612 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02427802) |
| January 28, 2015 | NCT02348541 | Usability of the CollaGUARD Adhesion Barrier Following Hysteroscopic Adhesiolysis | Innocoll | Not applicable | Completed | Hysteroscopic Adhesiolysis | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02348541) |
| September 5, 2014 | NCT02232178 | Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant | Innocoll | Phase 2 | Completed | Hernioplasty | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02232178) |
| October 19, 2010 | NCT01224145 | Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy | Innocoll | Phase 2 | Completed | Hernia, Postoperative Pain | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01224145) |
| October 13, 2010 | NCT01220024 | Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy | Innocoll | Phase 2 | Completed | Herniorrhaphy, Postoperative Pain, Inguinal Hernia | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01220024) |
| September 9, 2008 | NCT00749749 | Efficacy and Safety of the CollaRx Bupivacaine Implant Compared to the ON-Q Painbuster Following Abdominal Hysterectomy | Innocoll | Phase 2 | Completed | Pain, Postoperative | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00749749) |
| April 18, 2008 | NCT00661466 | Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery | Innocoll | Phase 2 | Terminated | Pain, Postoperative | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00661466) |
| April 16, 2008 | NCT00659646 | The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers | Innocoll | Phase 2 | Completed | Diabetic Foot Ulcer | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00659646) |
| April 16, 2008 | NCT00658957 | Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer | Innocoll | Phase 2 | Terminated | Diabetic Foot Ulcer | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00658957) |
| February 29, 2008 | NCT00626886 | Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy | Innocoll | Phase 2 | Completed | Postoperative Pain, Inguinal Hernia | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00626886) |
| February 28, 2008 | NCT00624910 | Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy | Innocoll | Phase 2 | Completed | Postoperative Pain | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00624910) |
| January 25, 2008 | NCT00600925 | A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection | Innocoll | Phase 3 | Completed | Colorectal Surgery, Surgical Wound Infection | 602 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00600925) |
| January 25, 2008 | NCT00600483 | Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection | Innocoll | Phase 3 | Completed | Cardiac Surgery, Sternal Wound Infection | 1,502 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00600483) |
| January 15, 2008 | NCT00593567 | Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer | Innocoll | Phase 2 | Completed | Diabetic Foot Ulcer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00593567) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 2 | 10 |
| Phase 3 | 9 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 18 |
| Terminated | 2 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain, Postoperative | 11 |
| Diabetic Foot | 5 |
| Diabetes Mellitus | 3 |
| Infections | 3 |
| Hernia, Inguinal | 3 |
| Hernia | 2 |
| Pain | 2 |
| Agnosia | 2 |
| Foot Ulcer | 1 |
| Ulcer | 1 |
| Obesity | 1 |
| Surgical Wound Infection | 1 |
| Hernia, Ventral | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Financial services firms in the United States](https://specstream.ai/data/businesses/financial-services-firms/united-states)
- [Shutters companies in the United States](https://specstream.ai/data/businesses/shutters-companies/united-states)
- [Diners in the United States](https://specstream.ai/data/businesses/diners/united-states)
- [Prenatal and perinatal care clinics in the United States](https://specstream.ai/data/businesses/prenatal-and-perinatal-care-clinics/united-states)
- [Carpenters in the United States](https://specstream.ai/data/businesses/carpenters/united-states)
- [Neurology practices in the United States](https://specstream.ai/data/businesses/neurology-practices/united-states)
